Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus
Page menu

The connected cap that can help keep your Patients Stay on Track with their insulin**

The challenge of insulin treatment management can put patients’ glycemic targets at risk.1-5

People living with diabetes reported that diabetes and insulin management lead to lifestyle modifications that require effort and sacrifices which can feel stressful and exhausted.1,2

Missed or incorrect administration of insulin can put your patients’ glycemic targets at risk.3-5

Connected insulin devices may help your patients improve their insulin
management.1,4,6


Provide accurate
patient data8,9
Support treatment
satisfaction*1
Help improve
insulin adherence*4,6

Discover SoloSmart®: The connected cap that can help keep your
Sanofi Solostar® patients on track with their insulin injections8,9

*Evaluated in studies using connected caps but did not use SoloSmart® brand.1,4,6,7;
**SoloSmart® allows people to inject with their pen as usual. Refer to the pen Instructions for Use for the safety test (priming) and injection instructions.

References

  1. Galindo et al Journal of Diabetes Science and Technology 2021;
  2. Pera PI, Patient Preference and Adherence 2011;
  3. Andrade C, et al. BMJ Open 2017;7:e018094;
  4. Munshi M, et al. Diabetes Care. 2019;42(6):1129 1131;
  5. Randlov J, et al. J Diabetes Sci Technol 2008;2:229 235 ;
  6. Sy et al, Journal of Diabetes Science and Technology 2020;
  7. Adolfsson et al. Diabetes and therapeutics 2020;
  8. SoloSmart® Instructions for Use;
  9. SoloSmart® technical note

Easy. Reliable. Empowering.

SoloSmart®, the solution that can provide you with a missing link in your diabetes practice: reliable and complete insulin tracking information8

  • Simplifies your patients ' insulin tracking routine:
    • Easy to set-up and use cap device8
    • Same use environment as their compatible injection pen8**
    • Automatically logs your patient’s insulin injections8,9
SoloSmart®* solution can help make insulin tracking easy for your patients8

 

  • Gathers accurate insulin information
    • Record accurately insulin injections parameters (date, time, dose)8,9
    • Real time data transfer, through Bluetooth technology8,9
    • Recorded data can be shared with you via  clinic portal8,9

SoloSmart®* solution provides a reliable support to your insulin therapeutic discussions and decisions8,9

 

  • Empowers your patients in their insulin management with:
    • Their Glucose level, recommended and injected insulin dose data via   app
    • Comprehensive and real-time overview of their insulin injection data via 8,9 

SoloSmart®* may help increase your patients’ understanding of the interconnection between their insulin injections and glycemic profile through the insulin data recorded by the device.8

Invite your patients to try SoloSmart®*: Help them get on top of their insulin management.8,9


 The connected cap that helps keep your Sanofi SoloStar® pens patients on track with their insulin injections1,2

SoloSmart® is a connected cap that is intended to be used by people with diabetes using Sanofi SoloStar® disposable insulin pens aged 14-80 years old. SoloSmart® should never be used with any other pens2. SoloSmart® can be mounted on top of Sanofi disposable insulin pens and is transferrable when changing pen2. SoloSmart® records insulin injection data (date, time and dose injected). SoloSmart® requires a compatible app (My Dose CoachTM) to visualize the recorded insulin injection data. SoloSmart® is not provided with Sanofi disposable insulin pens and is sold separately (SoloStar® pens are available for; Toujeo® (insulin glargine 300 U/mL), Soliqua® (insulin glargine 100 U/mL + Lixisenatide) and Lantus® (insulin glargine 100 U/ml). *For more information, refer to the following:  1. SoloSmart® Instructions for Use “IFU” 2. SoloSmart® technical note

- 
Solution connects People with Diabetes to their HCPs and integrates glucose data with Insulin data

*PwD= People with diabetes
** Dummy data for illustration purpose only.

References

  1. For more information refer to SoloSmart IFU and technical note.
  2. Patients using Sanofi SoloStar pens; Toujeo, Soliqua or Lantus.

HCP Start →

Soliqua API Toujeo API

SoloSmart is approved in Saudi Arabia under authorization number: MDMA-2-2024-0038

My Dose Coach is not intended to replace the care or advice of a healthcare team
My Dose Coach is approved in Saudi Arabia under authorization number: GHTF-2020-2084

MAT-SA-2400096/v1/Apr 2024